– Tan\u0131 koymada gecikme \u00f6l\u00fcm oranlar\u0131n\u0131 y\u00fckseltiyor <\/p>\n
Erkek \u00fcreme sisteminin bir par\u00e7as\u0131 olan prostat bezinde geli\u015fen ve erkeklerde en s\u0131k tan\u0131 konulan ikinci kanser t\u00fcr\u00fc olan prostat kanserinden d\u00fcnyada her y\u0131l 350 bin\u2019den fazla ki\u015fi hayat\u0131n\u0131 kaybediyor.
\n Ba\u015fak\u015fehir \u00c7am ve Sakura \u015eehir Hastanesi \u00dcroloji uzman\u0131 Prof. Dr. Halil L\u00fctfi Canat, d\u00fcnyada her y\u0131l 1.5 milyon\u2019a yak\u0131n yeni vaka g\u00f6r\u00fclmekte oldu\u011funa dikkat \u00e7ekerek, “Zaman\u0131nda tarama testlerinin yap\u0131lmamas\u0131 ve prostat kanserinin \u00e7o\u011fu zaman erken evrede belirti vermemesi nedeniyle tan\u0131 koymada gecikme, bu hastal\u0131\u011f\u0131n tedavisini zorla\u015ft\u0131rmakta ve maalesef \u00f6l\u00fcm oranlar\u0131n\u0131 art\u0131rmaktad\u0131r” dedi.
\n Prostat kanserinde erken tan\u0131n\u0131n, tedavide ba\u015far\u0131 \u015fans\u0131n\u0131 belirleyen en \u00f6nemli fakt\u00f6rlerden biri oldu\u011funun alt\u0131n\u0131 \u00e7izen Canat, “G\u00fcn\u00fcm\u00fczde prostat kanseri taramas\u0131nda, 50 ya\u015f\u0131ndan itibaren kanda bak\u0131lan PSA (Prostat Spesifik Antijen) testi ve parmakla rektal muayene yap\u0131lmaktad\u0131r. \u015e\u00fcpheli durumlarda manyetik rezonans (MR) g\u00f6r\u00fcnt\u00fcleme ve sonras\u0131nda yap\u0131lan biyopsi tan\u0131y\u0131 kesinle\u015ftirmek i\u00e7in uygulan\u0131r. \u00d6zellikle aile \u00f6yk\u00fcs\u00fc bulunan ve genetik yatk\u0131nl\u0131\u011f\u0131 olan y\u00fcksek riskli bireylerde taraman\u0131n, 40-45 ya\u015flar\u0131nda ba\u015flat\u0131lmas\u0131 \u00f6nerilmektedir. Hastal\u0131k ilerledi\u011finde s\u0131k idrara \u00e7\u0131kma, gece idrara kalkma, idrar ak\u0131\u015f\u0131nda zay\u0131flama, idrarda ya da menide kan g\u00f6r\u00fclmesi ve bel veya kal\u00e7a b\u00f6lgesinde a\u011fr\u0131 gibi belirtiler ortaya \u00e7\u0131kabilir. Bu gibi belirtiler varl\u0131\u011f\u0131nda da prostat kanseri ara\u015ft\u0131rmas\u0131 yap\u0131lmal\u0131d\u0131r. Prostat kanseri i\u00e7in risk fakt\u00f6rleri aras\u0131nda ya\u015f en \u00f6nemli unsurlardan biridir ve 50 ya\u015f\u0131n \u00fczerindeki erkeklerde g\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131 belirgin \u015fekilde artmaktad\u0131r. Bunun yan\u0131 s\u0131ra, aile \u00f6yk\u00fcs\u00fc de \u00f6nemli bir risk fakt\u00f6r\u00fcd\u00fcr ki; birinci derece akrabas\u0131nda prostat kanseri bulunan erkeklerin hastal\u0131\u011fa yakalanma ihtimali belirgin olarak artmaktad\u0131r. Ayr\u0131ca sa\u011fl\u0131ks\u0131z ya\u015fam tarz\u0131, obezite, doymu\u015f ya\u011fdan zengin beslenme ve fiziksel hareketsizlik de riski y\u00fckselten unsurlar aras\u0131ndad\u0131r” dedi.
\n Prostat kanserinden korunmak i\u00e7in sa\u011fl\u0131kl\u0131 ya\u015fam al\u0131\u015fkanl\u0131klar\u0131n\u0131n olduk\u00e7a \u00f6nemli oldu\u011funu belirten Canat, “D\u00fczenli egzersiz yapmak, sebze, meyve ve liften zengin dengeli bir beslenme d\u00fczeni benimsemek, k\u0131rm\u0131z\u0131 et ve ya\u011f oran\u0131 y\u00fcksek g\u0131dalar\u0131 s\u0131n\u0131rlamak, sigara ve alkol t\u00fcketimi olmamas\u0131 riskin d\u00fc\u015f\u00fcr\u00fclmesine katk\u0131 sa\u011flar. Prostat kanseri tedavisinde hastal\u0131\u011f\u0131n evresi, t\u00fcm\u00f6r\u00fcn biyolojik \u00f6zellikleri ve hastan\u0131n genel sa\u011fl\u0131k durumu dikkate al\u0131n\u0131r. Erken evre ve d\u00fc\u015f\u00fck riskli hastalarda aktif izlem se\u00e7ene\u011fi g\u00fcndeme gelirken, hastal\u0131\u011f\u0131n evresine g\u00f6re cerrahi tedavi, radyoterapi, hormon tedavisi, kemoterapi ve yeni nesil hedefe y\u00f6nelik tedaviler de uygulanabilmektedir. Sonu\u00e7 olarak prostat kanseri, erken te\u015fhis edildi\u011finde tedavi ba\u015far\u0131s\u0131n\u0131n y\u00fcksek oldu\u011fu ve \u00f6l\u00fcm oranlar\u0131n\u0131n olduk\u00e7a d\u00fc\u015f\u00fck oldu\u011fu bir hastal\u0131kt\u0131r. 15 Eyl\u00fcl D\u00fcnya Prostat Kanseri Fark\u0131ndal\u0131k G\u00fcn\u00fc, toplumda bu konuda bilin\u00e7 olu\u015fturmak, d\u00fczenli taramalar\u0131n ve sa\u011fl\u0131kl\u0131 ya\u015fam tarz\u0131n\u0131n \u00f6nemini vurgulamak i\u00e7in \u00f6nemli bir f\u0131rsat sunmaktad\u0131r” dedi. <\/p>\n
13.09.2025 <\/p>\n","protected":false},"excerpt":{"rendered":"
– Tan\u0131 koymada gecikme \u00f6l\u00fcm oranlar\u0131n\u0131 y\u00fckseltiyor Erkek \u00fcreme sisteminin bir par\u00e7as\u0131 olan prostat bezinde geli\u015fen ve erkeklerde en s\u0131k tan\u0131 konulan ikinci kanser t\u00fcr\u00fc olan prostat kanserinden d\u00fcnyada her y\u0131l 350 bin\u2019den fazla ki\u015fi hayat\u0131n\u0131 kaybediyor. Ba\u015fak\u015fehir \u00c7am ve Sakura \u015eehir Hastanesi \u00dcroloji uzman\u0131 Prof. Dr. Halil L\u00fctfi Canat, d\u00fcnyada her y\u0131l 1.5 milyon\u2019a […]<\/p>\n","protected":false},"author":1,"featured_media":11629,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[49],"tags":[],"class_list":["post-11628","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-kose-yazilari"],"yoast_head":"\n